Author

Mary Murphy

Boehringer Ingelheim (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Developmental Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Adelaine Kwun-Wai LeungiD· 1 shared Alan A. MelcheriD· 1 shared Anand Krishnan Nambisan· 1 shared Anne B. VogtiD· 1 shared Anton PatrikeeviD· 1 shared Antonio RullaniD· 1 shared Charleen Chan Wah HakiD· 1 shared Christian MandliD· 1 shared

Activity by Year

2020-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Adelaine Kwun-Wai LeungORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Spatial transcriptomics defines the mechanisms of hiPSC derived stem cell mediated repair in human articular cartilage

Y.F. Ramos, Sayedeh Sana Sayedipour, Georgina Shaw, Margo Tuerlings, Timo Schomann, H. Eka D. Suchiman, Davy Cats, Frank Barry, Rachid Mahdad, Hailiang Mei, Luis Javier Cruz, Mary Murphy, Ingrid Meulenbelt

The paper evaluates the therapeutic effects of hiMSCs in osteoarthritis models, showing reduced damage and activation of cholesterol pathways, with spatial transcriptomics revealing localized molecular changes.

bioRxiv · Jul 23, 2026 · PreprintDevelopmental Biology

Preclinical efficacy of a systemically-administered, second-generation STING agonist that promotes antitumour immunity in combination with radiotherapy

Malin Pedersen, Lisa C. Hubbard, Shane Foo, Anton Patrikeev, Antonio Rullan, Holly Baldock, Christian Mandl, Paolo Chetta, Jehanne Hassan, Isaac Dean, Naomi Guppy, Philippe Slos, Charleen Chan Wah Hak, Elizabeth S. Appleton, Emmanuel Christian Patin, , Kevin J Harrington

This study evaluates a second-generation STING agonist, BI-1703880, showing that combining it with radiotherapy enhances antitumour immunity and immune memory.

bioRxiv · Mar 25, 2026 · PreprintCancer Biology

Identification and Mechanistic Characterization of a Novel Peptide Inhibitor of Glycogen Synthase Kinase (GSK3) Derived from the Disrupted in Schizophrenia 1 (DISC1) Protein

Stephanie L. Saundh, Debasis Patnaik, Steve Gagné, Joshua A. Bishop, Sean Lipsit, Samat Amat, Narsimha Pujari, Anand Krishnan Nambisan, Robert M. Bigsby, Mary Murphy, Li‐Huei Tsai, Stephen J. Haggarty, Adelaine Kwun-Wai Leung

This study identifies and characterizes a novel 44-mer peptide from DISC1 that inhibits GSK3β in a non-competitive manner, offering a new approach for developing selective GSK3β inhibitors.

ACS Chemical Neuroscience · Nov 30, 2020Peer-reviewedNeuroscience